Luke, J. J., Warner, A. B., Chmielowski, B., Diab, A., Gebhardt, C., Hernandez-Aya, L. F., Hu-Lieskovan, S., Karapetyan, L., Lawrence, D. P., McKean, M., Mitchell, T. C., Moschos, S. J., Moser, J. C., Olszanski, A. J., Patel, S. P., Schadendorf, D., Smithy, J. W., Truong, T., Wermke, M., Britten, C. (2025). SUPRAME: A phase 3 trial comparing IMA203, an engineered T-cell receptor expressing T cell therapy (TCR-T) vs investigator’s choice in patients with previously treated advanced cutaneous melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2673